A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Hoffmann-La Roche
- Study ID
- NCT04409262
- Phase
- PHASE3
- Status
- Completed
Conditions
- COVID-19 Pneumonia
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Remdesivir — DRUGParticipants will receive intravenous (IV) RDV
- Tocilizumab — DRUGParticipants will receive IV TCZ
- Placebo — DRUGParticipants will receive IV placebo matched to TCZ
Study Details
This study will evaluate the efficacy and safety of combination therapy with remdesivir plus tocilizumab compared with remdesivir plus placebo in hospitalized patients with COVID-19 pneumonia.
Key Dates
- Start date
- Jun 16, 2020
- Status verified
- Jan 2022
- Primary completion
- Feb 1, 2021
- Completion
- Mar 8, 2021
Study Design
- Enrollment
- 649 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Remdesivir + Tocilizumab (RDV+TCZ)Participants assigned to the RDV+TCZ arm will receive a 10-day treatment course of RDV, plus one infusion of TCZ on Day 1.
- Active Comparator: Remdesivir + Placebo (RDV+Placebo)Participants assigned to the RDV+ placebo arm will receive a 10-day treatment course of RDV, plus one infusion of TCZ-placebo on Day 1.
Primary Outcome Measure
Time to Hospital Discharge or "Ready for Discharge" up to Day 28 [ Time Frame: Up to Day 28 ]
Locations (38)
Find similar trials in Phoenix, AZ
By research site
Valleywise Health Medical Center· Phoenix, AZeStudySite - Chula Vista - PPDS· Chula Vista, CAHoag Hospital Irvine· Irvine, CAProvidence St Johns Health Center· Santa Monica, CAYale University School of Medicine; HIV Clinical Trials Program· New Haven, CTMedstar Georgetown University Hospital· Washington D.C., DC
Related Studies
- Cardiac Magnetic Resonance Tissue Characterization in COVID-19 SurvivorsRecruiting · Weill Medical College of Cornell University · Brooklyn, New York
- Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational MedicineRecruiting · The Geneva Foundation · Fort Sam Houston, Texas